Skip to main content
Erschienen in: Health Care Analysis 2/2010

01.06.2010 | Original Article

Public Financing of IVF: A Review of Policy Rationales

verfasst von: Philipa Mladovsky, Corinna Sorenson

Erschienen in: Health Care Analysis | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

There is great diversity in in vitro fertilization (IVF) funding and reimbursement policies and practice throughout Europe and the rest of the world. While many existing reimbursement and regulatory frameworks address safety and legal concerns, economic factors also assume a central role. However, there are several problems with the evidence that is available on the economics of IVF. This suggests there is a need for more robust cost-effectiveness studies. It also indicates the need for alternative rationales to justify the reimbursement of IVF, which might more fully account for the social, political, ethical, and philosophical considerations embedded in notions of infertility and technology-driven reproductive treatments. The merits and limitations of five alternative rationales are discussed. The review suggests that while no existing single rationale provides a complete framework with which to support funding decisions, taken together they provide guideposts which signal important issues for consideration and highlight where further research, action, and debate are needed.
Fußnoten
1
Other ART treatments include intra cyto-plasmic sperm injection (ICSI), frozen embryo replacement (FER), egg donation (ED), in vitro maturation (IVM), and preimplantation genetic diagnosis/screening (PGD/PGS).
 
2
WTP places the relative benefits of a treatment in monetary, rather than health-related, terms.
 
3
There may be other, ethical, reasons for excluding ‘socially infertile’ women from IVF treatment. For example, Sect. 13(5) of the UK Human Fertilization and Embryology Act 1990 states that: “a woman shall not be provided with treatment services unless account has been taken of the welfare of the child who may be born as a result of the treatment (including the need of that child for a father), and of any other child who may be affected by the birth”.
 
4
It is not clear whether the survey distinguished between the cost of three successful cycles as compared to the cost of a successful hip replacement or simply the unit cost. If only the unit cost was used, the ‘real’ cost of IVF was probably seriously under-estimated as compared to the cost of a hip replacement.
 
5
FINRRAGE is opposed to genetic research which, they argue, promotes the commodification of life and a ‘new’ eugenics seeking to create perfect ‘designer’ children. It is, however, beyond the scope of this article to discuss the arguments for and against genetic research.
 
6
The main policies that have been employed by governments to address population ageing can be divided into two groups: 1) demographic policies, specifically immigration and family support measures aimed at increasing fertility and 2) welfare-related policies, such as increasing labour force participation, raising the age of retirement, and reducing public pension benefits [4].
 
7
The low fertility trap entails a country’s TFR falling to less than 1.5, causing a relatively rapid decline in the birth rate, as the small cohorts born in many European countries since the mid 1980 s reach reproductive age.
 
Literatur
1.
Zurück zum Zitat Adashi, E. Y., et al. (2000). Public perception on infertility and its treatment: An international survey. The Bertarelli Foundation Scientific Board. Human Reproduction (Oxford, England), 15(2), 330–334. doi:10.1093/humrep/15.2.330.CrossRef Adashi, E. Y., et al. (2000). Public perception on infertility and its treatment: An international survey. The Bertarelli Foundation Scientific Board. Human Reproduction (Oxford, England), 15(2), 330–334. doi:10.​1093/​humrep/​15.​2.​330.CrossRef
2.
Zurück zum Zitat Andersen, A. N., Gianaroli, L. R., Felberbaum, J., Mouzon, J., & Nygren, K. G. (2006). Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction (Oxford, England). doi:10.1093/humrep/del075. Andersen, A. N., Gianaroli, L. R., Felberbaum, J., Mouzon, J., & Nygren, K. G. (2006). Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction (Oxford, England). doi:10.​1093/​humrep/​del075.
5.
Zurück zum Zitat Britt, E. C. (2001). Conceiving normalcy: Rhetoric, law, and the double binds of infertility. Rhetoric, culture, and social critique (Vol. xi, p. 206). Tuscaloosa: University of Alabama Press. Britt, E. C. (2001). Conceiving normalcy: Rhetoric, law, and the double binds of infertility. Rhetoric, culture, and social critique (Vol. xi, p. 206). Tuscaloosa: University of Alabama Press.
8.
Zurück zum Zitat Caldwell, J., Caldwell, P., & McDonald, P. (2002). Policy responses to low fertility and its consequences: A global survey. Journal of Population Research, 19(1), 1–24.CrossRef Caldwell, J., Caldwell, P., & McDonald, P. (2002). Policy responses to low fertility and its consequences: A global survey. Journal of Population Research, 19(1), 1–24.CrossRef
9.
Zurück zum Zitat Campagne, D. M. (2006). Should fertilization treatment start with reducing stress? Human Reproduction, 21(7), 1651–1658. Jul.CrossRefPubMed Campagne, D. M. (2006). Should fertilization treatment start with reducing stress? Human Reproduction, 21(7), 1651–1658. Jul.CrossRefPubMed
11.
Zurück zum Zitat Collins, J. A., & Rowe, T. C. (1989). Age of the female partner is a prognostic factor in prolonged unexplained infertility: A multicenter study. Fertility and Sterility, 52(1), 15–20.PubMed Collins, J. A., & Rowe, T. C. (1989). Age of the female partner is a prognostic factor in prolonged unexplained infertility: A multicenter study. Fertility and Sterility, 52(1), 15–20.PubMed
13.
Zurück zum Zitat Daniels, N. (1985). Just health care. Cambridge: Cambridge University Press. Daniels, N. (1985). Just health care. Cambridge: Cambridge University Press.
14.
Zurück zum Zitat Devlin, N., & Parkin, D. (2003). Funding fertility: Issues in the allocation and distribution of resources to assisted reproduction technologies. Human Fertility (Cambridge, England), 6(2, Suppl), S2–S6. doi:10.1080/1464770312331369153.CrossRef Devlin, N., & Parkin, D. (2003). Funding fertility: Issues in the allocation and distribution of resources to assisted reproduction technologies. Human Fertility (Cambridge, England), 6(2, Suppl), S2–S6. doi:10.​1080/​1464770312331369​153.CrossRef
15.
Zurück zum Zitat Egnatz, D. G., et al. (1980). DBCP and testicular effects in chemical workers: An epidemiological survey in Midland, Michigan. Journal of Occupational Medicine, 22(11), 727–732.PubMed Egnatz, D. G., et al. (1980). DBCP and testicular effects in chemical workers: An epidemiological survey in Midland, Michigan. Journal of Occupational Medicine, 22(11), 727–732.PubMed
16.
Zurück zum Zitat Eijkemans, M. J., Polinder, S., Mulders, A. G., Laven, J. S., Habbema, J. D., & Fauser, B. C. (2005). Individualized cost-effectiveness conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Human Reproduction (Oxford, England), 20(10), 2830–2837. doi:10.1093/humrep/dei164. Epub 2005 July.CrossRef Eijkemans, M. J., Polinder, S., Mulders, A. G., Laven, J. S., Habbema, J. D., & Fauser, B. C. (2005). Individualized cost-effectiveness conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Human Reproduction (Oxford, England), 20(10), 2830–2837. doi:10.​1093/​humrep/​dei164. Epub 2005 July.CrossRef
17.
Zurück zum Zitat European Society of Human Reproduction, Embryology Task Force on Ethics, Law. (2003). Ethical issues related to multiple pregnancies in medically assisted procreation. Human Reproduction (Oxford, England), 18(9), 1976–1979. doi:10.1093/humrep/deg357.CrossRef European Society of Human Reproduction, Embryology Task Force on Ethics, Law. (2003). Ethical issues related to multiple pregnancies in medically assisted procreation. Human Reproduction (Oxford, England), 18(9), 1976–1979. doi:10.​1093/​humrep/​deg357.CrossRef
18.
Zurück zum Zitat Garceau, L., Henderson, J., Davis, L. J., Petrou, S., Henderson, L. R., McVeigh, E., et al. (2002). Economic implications of assisted reproductive techniques: A systematic review. Human Reproduction (Oxford, England), 17(12), 3090–3109. doi:10.1093/humrep/17.12.3090.CrossRef Garceau, L., Henderson, J., Davis, L. J., Petrou, S., Henderson, L. R., McVeigh, E., et al. (2002). Economic implications of assisted reproductive techniques: A systematic review. Human Reproduction (Oxford, England), 17(12), 3090–3109. doi:10.​1093/​humrep/​17.​12.​3090.CrossRef
20.
Zurück zum Zitat Giacomini, M., Hurley, J., & Stoddart, G. (2000). The many meanings of deinsuring a health service: The case of in vitro fertilization in Ontario. Social Science & Medicine, 50(10), 1485–1500.CrossRef Giacomini, M., Hurley, J., & Stoddart, G. (2000). The many meanings of deinsuring a health service: The case of in vitro fertilization in Ontario. Social Science & Medicine, 50(10), 1485–1500.CrossRef
21.
Zurück zum Zitat Gissler, M., Silverio, M. M., & Hemminki, E. (1995). In-vitro fertilization pregnancies and prenatal health in Finland 1991–1993. Human Reproduction, 10, 1856–1861.PubMed Gissler, M., Silverio, M. M., & Hemminki, E. (1995). In-vitro fertilization pregnancies and prenatal health in Finland 1991–1993. Human Reproduction, 10, 1856–1861.PubMed
22.
Zurück zum Zitat Gissler, M., & Tiitinen, A. (2001). IVF treatments and their outcomes in Finland in the 1990s. Acta Obstetricia et Gynecologica Scandinavica, 80(10), 937–944.CrossRefPubMed Gissler, M., & Tiitinen, A. (2001). IVF treatments and their outcomes in Finland in the 1990s. Acta Obstetricia et Gynecologica Scandinavica, 80(10), 937–944.CrossRefPubMed
23.
Zurück zum Zitat Goldfarb, J. N., Austin, C., Lisbona, H., Peskin, B., & Clapp, M. (1996). Cost-effectiveness of in vitro fertilization. Obstetrics and Gynecology, 87, 18–21.CrossRefPubMed Goldfarb, J. N., Austin, C., Lisbona, H., Peskin, B., & Clapp, M. (1996). Cost-effectiveness of in vitro fertilization. Obstetrics and Gynecology, 87, 18–21.CrossRefPubMed
24.
Zurück zum Zitat Grant, J., Hoorens, S., Gallo, F., & Cave, J. (2006). Should ART be part of a population policy mix? a preliminary assessment of the demographic and economic impact of assisted reproductive technologies. Europe: RAND. Grant, J., Hoorens, S., Gallo, F., & Cave, J. (2006). Should ART be part of a population policy mix? a preliminary assessment of the demographic and economic impact of assisted reproductive technologies. Europe: RAND.
25.
Zurück zum Zitat Gunnell, D. J., & Ewings, P. (1994). Infertility prevalence, needs assessment and purchasing. Journal of Public Health Medicine, 16, 29–36.PubMed Gunnell, D. J., & Ewings, P. (1994). Infertility prevalence, needs assessment and purchasing. Journal of Public Health Medicine, 16, 29–36.PubMed
29.
Zurück zum Zitat Hull, M. G., et al. (1985). Population study of causes, treatment, and outcome of infertility. British Medical Journal (Clinical Research Ed.), 291(6510), 1693–1697.CrossRef Hull, M. G., et al. (1985). Population study of causes, treatment, and outcome of infertility. British Medical Journal (Clinical Research Ed.), 291(6510), 1693–1697.CrossRef
31.
Zurück zum Zitat Iowa. Supreme Court. (1988). Witcraft v. Sundstrand Health and Disability Group Benefit Plan. West's North Western Reporter, 420, 785–790. Iowa. Supreme Court. (1988). Witcraft v. Sundstrand Health and Disability Group Benefit Plan. West's North Western Reporter, 420, 785–790.
33.
Zurück zum Zitat Jose-Miller, A. B., Boyden, J. W., & Frey, K. A. (2007). Infertility. American Family Physician, 75(6), 849–856.PubMed Jose-Miller, A. B., Boyden, J. W., & Frey, K. A. (2007). Infertility. American Family Physician, 75(6), 849–856.PubMed
34.
Zurück zum Zitat Katz, P., Nachtigall, R., & Showstack, J. (2002). The economic impact of the assisted reproductive technologies. Nature Cell Biology and Nature Medicine. Published on-line at: www.nature.com/fertility. Katz, P., Nachtigall, R., & Showstack, J. (2002). The economic impact of the assisted reproductive technologies. Nature Cell Biology and Nature Medicine. Published on-line at: www.​nature.​com/​fertility.
35.
Zurück zum Zitat Kennedy, R., et al. (2006). Implementation of the NICE guideline—recommendations from the British Fertility Society for national criteria for NHS funding of assisted conception. Human Fertility (Cambridge, England), 9(3), 181–189. doi:10.1080/14647270600908411.CrossRef Kennedy, R., et al. (2006). Implementation of the NICE guideline—recommendations from the British Fertility Society for national criteria for NHS funding of assisted conception. Human Fertility (Cambridge, England), 9(3), 181–189. doi:10.​1080/​1464727060090841​1.CrossRef
38.
Zurück zum Zitat Ledger, W. G., Hoorens, F., Ziebe, S., & Connolly, M. (2006). Abstracts of the 22nd annual meeting of the ESHRE, Prague, Czech Republic, 18–21 June 2006. present discounted value of children born using IVF compared with naturally conceived children: A simplified UK calculation. Human reproduction (Oxford, England), 21(Supplement 1), i74–i75. Ledger, W. G., Hoorens, F., Ziebe, S., & Connolly, M. (2006). Abstracts of the 22nd annual meeting of the ESHRE, Prague, Czech Republic, 18–21 June 2006. present discounted value of children born using IVF compared with naturally conceived children: A simplified UK calculation. Human reproduction (Oxford, England), 21(Supplement 1), i74–i75.
39.
Zurück zum Zitat Legro, R. S., Shakleford, D. P., Moessner, J. M., Gnatuk, C. L., & Dodson, W. C. (1997). ART in women 40 and over. Is it worth it? The Journal of Reproductive Medicine, 42(2), 76–82.PubMed Legro, R. S., Shakleford, D. P., Moessner, J. M., Gnatuk, C. L., & Dodson, W. C. (1997). ART in women 40 and over. Is it worth it? The Journal of Reproductive Medicine, 42(2), 76–82.PubMed
40.
Zurück zum Zitat Ludwig, A. K., Sutcliffe, A. G., Diedrich, K., & Ludwig, M. (2006). Post-neonatal health and development of children born after assisted reproduction: A systematic review of controlled studies. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 127(1), 3–25. doi:10.1016/j.ejogrb.2006.02.009.CrossRefPubMed Ludwig, A. K., Sutcliffe, A. G., Diedrich, K., & Ludwig, M. (2006). Post-neonatal health and development of children born after assisted reproduction: A systematic review of controlled studies. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 127(1), 3–25. doi:10.​1016/​j.​ejogrb.​2006.​02.​009.CrossRefPubMed
46.
Zurück zum Zitat Mladovsky, P. (2006). ART treatment in the EU: IVF and reproductive tourism. Euro Observer, 8(4), 5. Mladovsky, P. (2006). ART treatment in the EU: IVF and reproductive tourism. Euro Observer, 8(4), 5.
47.
Zurück zum Zitat Mol, B. J., Bonsel, G. J., Collins, J. A., Wiegerinck, M., Van Der Veen, F., & Bossuyt, P. M. (2001). Cost-effectiveness of in vitro fertilization and embryo transfer. Fertility and Sterility, 73, 748–754. doi:10.1016/S0015-0282(99)00610-X.CrossRef Mol, B. J., Bonsel, G. J., Collins, J. A., Wiegerinck, M., Van Der Veen, F., & Bossuyt, P. M. (2001). Cost-effectiveness of in vitro fertilization and embryo transfer. Fertility and Sterility, 73, 748–754. doi:10.​1016/​S0015-0282(99)00610-X.CrossRef
48.
Zurück zum Zitat National Collaborating Centre for Women’s, Children’s Health. (2004). Fertility assessment and treatment for people with fertility problems. Clinical guideline commissioned by NICE. London: RCOG Press. National Collaborating Centre for Women’s, Children’s Health. (2004). Fertility assessment and treatment for people with fertility problems. Clinical guideline commissioned by NICE. London: RCOG Press.
49.
Zurück zum Zitat Neumann, P. J. (1997). Should health insurance cover IVF? issues and options. Journal of Health Politics, Policy and Law, 22(5), 1215–1239.PubMed Neumann, P. J. (1997). Should health insurance cover IVF? issues and options. Journal of Health Politics, Policy and Law, 22(5), 1215–1239.PubMed
50.
Zurück zum Zitat Neumann, P. J., Gharib, S. D., & Weinstein, M. C. (1994). The cost of a successful delivery with in-vitro fertilization. NEJM, 331, 239–243.CrossRefPubMed Neumann, P. J., Gharib, S. D., & Weinstein, M. C. (1994). The cost of a successful delivery with in-vitro fertilization. NEJM, 331, 239–243.CrossRefPubMed
51.
Zurück zum Zitat Nygren, K. G., & Andersen, A. N. (2001). Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction (Oxford, England), 16(2), 384–391. doi:10.1093/humrep/16.2.384.CrossRef Nygren, K. G., & Andersen, A. N. (2001). Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction (Oxford, England), 16(2), 384–391. doi:10.​1093/​humrep/​16.​2.​384.CrossRef
52.
Zurück zum Zitat Oberlander, J., Marmor, T., & Jacobs, L. (2001). Rationing medical care: Rhetoric and reality in the Oregon Health Plan. Canadian Medical Association Journal, 164(11), 583–587. Oberlander, J., Marmor, T., & Jacobs, L. (2001). Rationing medical care: Rhetoric and reality in the Oregon Health Plan. Canadian Medical Association Journal, 164(11), 583–587.
54.
Zurück zum Zitat Population Commission United Nations. (1996). Reproductive rights and reproductive health: A concise report. POP/623, Geneva: United Nations. Population Commission United Nations. (1996). Reproductive rights and reproductive health: A concise report. POP/623, Geneva: United Nations.
55.
Zurück zum Zitat Rickard, M. (2001). Is it medically legitimate to provide assisted reproductive treatments to fertile lesbians and single women? Research paper No. 23 2000–01. Australia: Department of the Parliamentary Library. Rickard, M. (2001). Is it medically legitimate to provide assisted reproductive treatments to fertile lesbians and single women? Research paper No. 23 2000–01. Australia: Department of the Parliamentary Library.
56.
Zurück zum Zitat Slutsky, M., Levin, J. L., & Levy, B. S. (1999). Azoospermia and oligospermia among a large cohort of DBCP applicators in 12 countries. International Journal of Occupational and Environmental Health, 5(2), 116–122.PubMed Slutsky, M., Levin, J. L., & Levy, B. S. (1999). Azoospermia and oligospermia among a large cohort of DBCP applicators in 12 countries. International Journal of Occupational and Environmental Health, 5(2), 116–122.PubMed
57.
Zurück zum Zitat Smajdor, A. (2007). State-funded IVF will make us rich… or will it? Journal of Medical Ethics, 33(8), 468–469.CrossRefPubMed Smajdor, A. (2007). State-funded IVF will make us rich… or will it? Journal of Medical Ethics, 33(8), 468–469.CrossRefPubMed
59.
Zurück zum Zitat Sorenson, C. (2006). IVF/ART funding and reimbursement. Euro Observer, 8(4), 6–7. Sorenson, C. (2006). IVF/ART funding and reimbursement. Euro Observer, 8(4), 6–7.
61.
Zurück zum Zitat Suchartwatnachai, C., Wongkularb, A., Srisombut, C., Choktanasiri, W., Chinsomboon, S., & Rojanasakul, A. (2000). Cost-effectiveness of IVF in women 38 years and older. International Journal of Gynecology and Obstetrics: The Official Organ of the International Federation of Gynecology and Obstetrics, 69, 143–148. doi:10.1016/S0020-7292(99)00215-5. Suchartwatnachai, C., Wongkularb, A., Srisombut, C., Choktanasiri, W., Chinsomboon, S., & Rojanasakul, A. (2000). Cost-effectiveness of IVF in women 38 years and older. International Journal of Gynecology and Obstetrics: The Official Organ of the International Federation of Gynecology and Obstetrics, 69, 143–148. doi:10.​1016/​S0020-7292(99)00215-5.
62.
Zurück zum Zitat Sunde, A. (2007). Europe’s declining population and the contribution of ART. Pharmaceuticals. Policy and Law, 9, 79–89. Sunde, A. (2007). Europe’s declining population and the contribution of ART. Pharmaceuticals. Policy and Law, 9, 79–89.
63.
Zurück zum Zitat Surveillance, I. F. F. S. (2004). A survey of the current status of assisted reproductive technology procedures around the world. Fertility and Sterility, 81(4), S9–S54. Surveillance, I. F. F. S. (2004). A survey of the current status of assisted reproductive technology procedures around the world. Fertility and Sterility, 81(4), S9–S54.
64.
Zurück zum Zitat Sykes, D., Henk, J. O., Palmer, S. J., & van Loon, J. (2001). The cost-effectiveness of IVF in the UK: A comparison of three gonadotrophin treatments. Human Reproduction, 16(12), 2557–2562.CrossRefPubMed Sykes, D., Henk, J. O., Palmer, S. J., & van Loon, J. (2001). The cost-effectiveness of IVF in the UK: A comparison of three gonadotrophin treatments. Human Reproduction, 16(12), 2557–2562.CrossRefPubMed
65.
Zurück zum Zitat Tannsjo, T. (2007). Who should bear the cost of IVF? In search of a just solution. Reproductive Biomedicine Online, 14(Suppl 1), 149–157.CrossRef Tannsjo, T. (2007). Who should bear the cost of IVF? In search of a just solution. Reproductive Biomedicine Online, 14(Suppl 1), 149–157.CrossRef
66.
Zurück zum Zitat Templeton, A., Fraser, C., & Thompson, B. (1990). The epidemiology of infertility in Aberdeen. BMJ (Clinical Research Ed.), 301(6744), 148–152.CrossRef Templeton, A., Fraser, C., & Thompson, B. (1990). The epidemiology of infertility in Aberdeen. BMJ (Clinical Research Ed.), 301(6744), 148–152.CrossRef
67.
Zurück zum Zitat Throsby, K. (2004). When IVF fails: Feminism, infertility and the negotiation of normality (p. 223). Basingstoke: Palgrave Macmillan. Throsby, K. (2004). When IVF fails: Feminism, infertility and the negotiation of normality (p. 223). Basingstoke: Palgrave Macmillan.
68.
Zurück zum Zitat United Nations. (1948). Universal Declaration of Human Rights. Adopted and proclaimed by General Assembly resolution 217 A (III) of 10 December 1948. United Nations. (1948). Universal Declaration of Human Rights. Adopted and proclaimed by General Assembly resolution 217 A (III) of 10 December 1948.
69.
Zurück zum Zitat Verhaak, C. M., Smeenk, J. M., Evers, A. W., Kremer, J. A., Kraaimaat, F. W., & Braat, D. D. (2007). Women’s emotional adjustment to IVF: A systematic review of 25 years of research. Human Reproduction Update, 13(1), 27–36. doi:10.1093/humupd/dml040.CrossRefPubMed Verhaak, C. M., Smeenk, J. M., Evers, A. W., Kremer, J. A., Kraaimaat, F. W., & Braat, D. D. (2007). Women’s emotional adjustment to IVF: A systematic review of 25 years of research. Human Reproduction Update, 13(1), 27–36. doi:10.​1093/​humupd/​dml040.CrossRefPubMed
70.
Zurück zum Zitat Warnock, M. (2002). Making babies : Is there a right to have children? (Vol. vi, p. 120). New York: Oxford University Press. Warnock, M. (2002). Making babies : Is there a right to have children? (Vol. vi, p. 120). New York: Oxford University Press.
Metadaten
Titel
Public Financing of IVF: A Review of Policy Rationales
verfasst von
Philipa Mladovsky
Corinna Sorenson
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Health Care Analysis / Ausgabe 2/2010
Print ISSN: 1065-3058
Elektronische ISSN: 1573-3394
DOI
https://doi.org/10.1007/s10728-009-0114-3

Weitere Artikel der Ausgabe 2/2010

Health Care Analysis 2/2010 Zur Ausgabe